These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12585714)

  • 21. Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.
    Pollack VA; Alvarez E; Tse KF; Torgov MY; Xie S; Shenoy SG; MacDougall JR; Arrol S; Zhong H; Gerwien RW; Hahne WF; Senter PD; Jeffers ME; Lichenstein HS; LaRochelle WJ
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):423-35. PubMed ID: 17541593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral immune responses induced by anti-idiotypic antibody fusion protein of 6B11scFv/hGM-CSF in BALB/c mice.
    Chang XH; Ye X; Cui H; Feng J; Li Y; Zhu HL; Yang WL; Fu TY; Cheng HY; Guo HF
    Chin Med J (Engl); 2006 Jan; 119(2):131-9. PubMed ID: 16454995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.
    Fidarova EF; El-Emir E; Boxer GM; Qureshi U; Dearling JL; Robson MP; Begent RH; Trott KR; Pedley RB
    Clin Cancer Res; 2008 May; 14(9):2639-46. PubMed ID: 18451227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
    Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separation of two distinct tumor-associated antibodies in the serum of melanoma patients.
    Lewis MG; Phillips TM
    J Natl Cancer Inst; 1972 Sep; 49(3):915-7. PubMed ID: 4630549
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunohistological evaluation of melanoma using anti-human melanoma monoclonal antibody].
    Kageshita T; Jono M; Ono T; Arao T; Imai K
    Nihon Hifuka Gakkai Zasshi; 1983 Apr; 93(5):537-40. PubMed ID: 6352996
    [No Abstract]   [Full Text] [Related]  

  • 27. Repeated exposure of non-human primates to monoclonal antibody and fragments: pharmacokinetic studies and their implications for targeted therapy.
    Lashford LS; Elsom G; Clarke J; Gordon I; Kemshead JT
    Prog Clin Biol Res; 1988; 271():605-17. PubMed ID: 3136460
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunohistochemical analysis of antimelanoma monoclonal antibodies, with special reference to fetal tissue distribution.
    Kageshita T; Johno M; Ono T; Arao T; Imai K
    J Invest Dermatol; 1985 Dec; 85(6):535-7. PubMed ID: 3905976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and biodistribution of genetically engineered antibodies.
    Batra SK; Jain M; Wittel UA; Chauhan SC; Colcher D
    Curr Opin Biotechnol; 2002 Dec; 13(6):603-8. PubMed ID: 12482521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analytical methods used in pharmacokinetics studies for biotechnology drugs].
    Ju Z; Sun J
    Wei Sheng Yan Jiu; 2002 Apr; 31(2):133-5. PubMed ID: 12561554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody pharmacokinetics and pharmacodynamics.
    Lobo ED; Hansen RJ; Balthasar JP
    J Pharm Sci; 2004 Nov; 93(11):2645-68. PubMed ID: 15389672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A system of immunofluorescence in the study of tumour cells.
    Phillips TM; Lewis MG
    Rev Eur Etud Clin Biol; 1970 Nov; 15(9):1016-20. PubMed ID: 4927103
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative optical imaging of the pharmacokinetics of fluorescent-specific antibodies to tumor markers through tissuelike turbid media.
    Gannot I; Garashi A; Chernomordik V; Gandjbachkhe A
    Opt Lett; 2004 Apr; 29(7):742-4. PubMed ID: 15072377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the correction for radioactive decay in pharmacokinetic modeling.
    Williams LE; Odom-Maryon TL; Liu A; Chai A; Raubitschek AA; Wong JY; D'Argenio DZ
    Med Phys; 1995 Oct; 22(10):1619-26. PubMed ID: 8551986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody imaging of atherosclerosis and vascular injury.
    Miller DD
    Am J Card Imaging; 1992 Dec; 6(4):298-307. PubMed ID: 10147959
    [No Abstract]   [Full Text] [Related]  

  • 36. Histology image analysis for carcinoma detection and grading.
    He L; Long LR; Antani S; Thoma GR
    Comput Methods Programs Biomed; 2012 Sep; 107(3):538-56. PubMed ID: 22436890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunofluorescence imaging as a tool for studying the pharmacokinetics of a human monoclonal single chain fragment antibody.
    Ramjiawan B; Ariano RE; Mantsch HH; Maiti P; Jackson M
    IEEE Trans Med Imaging; 2002 Oct; 21(10):1317-23. PubMed ID: 12585714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.
    Baxter LT; Zhu H; Mackensen DG; Jain RK
    Cancer Res; 1994 Mar; 54(6):1517-28. PubMed ID: 8137258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.
    Wittel UA; Jain M; Goel A; Chauhan SC; Colcher D; Batra SK
    Nucl Med Biol; 2005 Feb; 32(2):157-64. PubMed ID: 15721761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.